Timothy Lynch

Keine laufenden Positionen mehr

Vermögen: 33 Mio $ am 30.09.2026

56 Jahre

74 Beziehungen

Health Technology

Finance

Consumer Services

Profil

Mr. Timothy P.
Lynch was previously employed as an Independent Director by InSite Vision, Inc., a Managing Member by Stonepine Capital Management LLC, an Independent Director by Nabi Biopharmaceuticals, an Independent Director by Allos Therapeutics, Inc., a President & Chief Executive Officer by Neurostat Pharmaceuticals, Inc., a President & Chief Executive Officer by Vivo Therapeutics, Inc., a Chief Financial Officer by Tercica, Inc., a Chief Financial Officer by InterMune, Inc., a Principal by Goldman Sachs & Co. LLC, and an Advisor by Healthcare Royalty Management LLC.
He also served on the board at Aradigm Corp., BioForm Medical, Inc., ClearFlow, Inc. and Elan Corp.
Plc.
He received his undergraduate degree from Colgate University and an MBA from Harvard University.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
Evolus, Inc. Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins 5.93%	17.04.2026	3’835’363 ( 5.93% )	31 Mio $	30.09.2026
AEON Biopharma, Inc. AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets 13.03%	19.08.2026	6’500’000 ( 13.03% )	2 Mio $	30.09.2026

Ehemalige bekannte Positionen von Timothy Lynch

Unternehmen	Position	Ende
Stonepine Capital Management LLC Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space.	Director of Investments	01.09.2024
Nabi Biopharmaceuticals Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products	Direktor/Vorstandsmitglied	31.12.2011
INSITE VISION INC.	Direktor/Vorstandsmitglied	16.09.2011
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics	Direktor/Vorstandsmitglied	04.06.2009
BioForm Medical, Inc. BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation	Direktor/Vorstandsmitglied	19.02.2010

Sehen Sie sich die Erfahrung von Timothy Lynch im Detail an

Ausbildung von Timothy Lynch

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Timothy Lynch im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	16
Elan Corp. Plc Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems	Health Technology
InSite Vision, Inc. InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products	Health Technology
Nabi Biopharmaceuticals Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products	Health Technology
Aradigm Corp. Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases	Health Technology
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics	Health Technology
InterMune, Inc. InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases	Health Technology
Tercica, Inc. Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders	Health Technology
BioForm Medical, Inc. BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation	Health Technology
ClearFlow, Inc. ClearFlow, Inc. Medical SpecialtiesHealth Technology Develops ICU surgical and medical devices	Health Technology
Stonepine Capital Management LLC Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space.	Finance
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Colgate University Colgate University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Healthcare Royalty Management LLC Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt.	Finance
Neurostat Pharmaceuticals, Inc.
Vivo Therapeutics, Inc.